This week, the Trump administration is calling for the return of the US military medical personnel, or MARs, to Afghanistan to assist with Afghan efforts to end the country’s longest war.
The move is being widely condemned by Afghan government officials and the US, which has been trying to negotiate a peace deal with the Taliban since the end of 2016.
The US military had agreed to allow US Marines to be deployed to Afghanistan in exchange for an end to the fighting.
But the Taliban, which seized power in the country in the 1980s, has repeatedly refused to let the US leave.
“The Taliban have repeatedly refused US requests to let American troops leave the country, citing security concerns and the risk of al-Qaeda infiltrating their country,” said a statement from the Pentagon.
“This means we are still unable to provide medical and other humanitarian aid to the Afghans.”
In response to the call, the Taliban said they would not accept the US return.
The Taliban said the military medical units would remain “at the front lines” and that they would continue to work alongside the Afghan government.
The White House statement came after a meeting of top military and administration officials on Tuesday.
The meeting was the first of its kind between the Trump team and top Afghan officials.
“We are still working closely with the Afghans on how best to provide the medical and logistical support to the Afghan forces that are still battling the Taliban,” a White House official said in a statement.
“As the fight against the Taliban intensifies, the Department of Defense will continue to do everything we can to support Afghan efforts and ensure the Afghan people get the best medical and humanitarian support possible.”
The Trump administration has struggled to keep track of how many troops are currently serving in Afghanistan, and the number is not expected to be finalised until later this year.
The Pentagon’s decision to allow the return comes just days after Afghan President Ashraf Ghani signed a peace agreement with the United States.